-
Venom extracts will not be interrupted/reduced
The production of venom extracts should not be interrupted due to ALK’s departure from the U.S. market.
-
What do you know about 95165?
从中介交流我们最近收到了ers suggest there may still be some confusion as to Medicare rules for allergy immunotherapy billing (CPT Cod…
-
碱性中断毒液过敏素nic Extract Production
ALK will no longer supply venom extracts in the U.S.
-
USP Chapter 797 update
Representatives of the College and AAAAI attended a very brief conference call with the United States Pharmacopeia (USP) on Feb. 26 regarding their timeline fo…
-
How many MUE’s can be billed in a day?
Both Medicare and Medicaid have national “medically unlikely edits” (MUEs) in place that are designed to automatically deny claims that exceed specific daily l…
-
15 years of allergen immunotherapy vial sterility testing
Can't see the PDF preview? Access it here.
-
Discussions with USP
Discussions with USPLeaders of the Advocacy Council and the College had a call with USP officials on Wednesday morning. We had requested it because we'd been t…
-
DASH FAQ
Are YOU ready to join the fight? Support DASH now.
-
Restricting the ability of physicians to prepare allergen extracts in their offices
Can't see the PDF preview? Access it here.
-
Ensuring the affordability of allergen immunotherapy in California and the United States
Can't see the PDF preview? Access it here.
-
House Committee stands up for allergists
An exciting victory in the fight for affordable immunotherapy for our patients! On April 19, the House Appropriations Committee approved the FY 2017 appropriat…
-
How to be an Advocate for Allergists
This webinar will address how allergists can impact issues important to the future of allergy by advocating at the local, state and federal level. Topics will …
-
Join the Congressional Asthma and Allergy Caucus (2017)
Can't see the PDF preview? Access it here.